MediPharm Labs

(OTC: MEDIF)
Healthcare  |  Drug Manufacturers - Specialty & Generic
3.31 -0.01 -0.3%
Stock Price | Oct. 18, 2019, 3:57 p.m.
1 Follower
Bid: 3.27
Ask: 3.29
Prev. Close: 3.32
52 Week Low: 0.9125
52 Week High: 5.65
PE Ratio: 19.062112
Dividend Yield: 0.0%

Company Summary

MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Weekend Edition 10/14/19

23 Comments
6 days ago

Premium Cannabis Stocks Review - Weekend Edition 10/07/19

23 Comments
1 week ago

Premium Changes to the Global Cannabis Stock Index

1 Comments
3 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 09/16/19

36 Comments
1 month ago

Premium Cannabis Stocks Review - Weekend Edition 09/03/19

30 Comments
1 month ago

Premium Cannabis Stocks Review - Weekend Edition 08/26/19

9 Comments
1 month ago

Premium How the Boneheads at ETF MJ Operate

1 Comments
2 months ago

Premium Is This a Good Time to Get in on the Canadian Extraction Action?

6 Comments
2 months ago

Premium Cannabis Stocks Review - Weekend Edition 07/29/19

11 Comments
2 months ago

Premium Cannabis Stocks Review - Weekend Edition 07/22/19

29 Comments
3 months ago